The honor of giving the opening keynote address during ELCC recognizes Dr. Hirsch’s significant contributions to international research and education. Read more
5th edition of patient education book released; US FDA moves to prohibit tobacco flavoring. Read more
Liquid biopsy tool may be useful in high-risk individuals unwilling or unable to undergo LDCT. Read more
The UK’s Dr. Charles Swanton received the ISLB’s 2021 award for outstanding scientific contribution. Read more
TTLC 2022 gets under way. WCLC registration now open but abstract submission deadline is coming soon. Read more
TTLC goes virtual. Positive results reported for pembrolizumab. GO2 Foundation names Chief of Healthcare Delivery. Read more
Experimental model systems are an indispensable part of research into SCLC. At the International Association for the Study of Lung Cancer’s 2021 Hot Topic Meeting: Small Cell Lung Cancer, keynote […] Read more
A growing body of research in SCLC has revealed greater phenotypic heterogeneity within this disease than previously realized. Circulating-tumor-cell-derived explant models (CDX) are providing researchers with a resource to facilitate […] Read more
Reducing complications after lung cancer surgery could generate positive changes across healthcare, from better outcomes and quality of life to cost savings. Even a small decrease in incidence of postoperative […] Read more
The results of two studies presented at the 2021 World Conference on Lung Cancer—LIBRETTO-321 and ARROW—indicate that the selective RET inhibitors selpercatinib and pralsetinib are promising treatment options for patients […] Read more